000178372 001__ 178372
000178372 005__ 20240229143544.0
000178372 0247_ $$2doi$$a10.1007/s10654-021-00824-7
000178372 0247_ $$2pmid$$apmid:34978665
000178372 0247_ $$2ISSN$$a0393-2990
000178372 0247_ $$2ISSN$$a1573-7284
000178372 037__ $$aDKFZ-2022-00022
000178372 041__ $$aEnglish
000178372 082__ $$a610
000178372 1001_ $$aHassan, Lamiaa$$b0
000178372 245__ $$aCardiovascular risk factors, living and ageing in Halle: the CARLA study.
000178372 260__ $$aDordrecht [u.a.]$$bSpringer Science + Business Media B.V.$$c2022
000178372 3367_ $$2DRIVER$$aarticle
000178372 3367_ $$2DataCite$$aOutput Types/Journal article
000178372 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1645446938_26267
000178372 3367_ $$2BibTeX$$aARTICLE
000178372 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000178372 3367_ $$00$$2EndNote$$aJournal Article
000178372 500__ $$a37, pages 103–116 (2022)
000178372 520__ $$aThe CARLA study (Cardiovascular Disease, Living and Ageing in Halle) is a longitudinal population-based cohort study of the general population of the city of Halle (Saale), Germany. The primary aim of the cohort was to investigate risk factors for cardiovascular diseases based on comprehensive cardiological phenotyping of study participants and was extended to study factors associated with healthy ageing. In total, 1779 probands (812 women and 967 men, aged 45-83 years) were examined at baseline (2002-2005), with a first and second follow-up performed 4 and 8 years later. The response proportion at baseline was 64.1% and the reparticipation proportion for the first and second follow-up was 86% and 77% respectively. Sixty-four percent of the study participants were in retirement while 25% were full- or partially-employed and 11% were unemployed at the time of the baseline examination. The currently running third follow-up focuses on the assessment of physical and mental health, with an intensive 4 h examination program, including measurement of cardiovascular, neurocognitive, balance and gait parameters. The data collected in the CARLA Study resulted in answering various research questions in over 80 publications, of which two thirds were pooled analyses with other similar population-based studies. Due to the extensiveness of information on risk factors, subclinical conditions and evident diseases, the biobanking concept for the biosamples, the cohort representativeness of an elderly population, and the high level of quality assurance, the CARLA cohort offers a unique platform for further research on important indicators for healthy ageing.
000178372 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000178372 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000178372 650_7 $$2Other$$aCardiovascular diseases
000178372 650_7 $$2Other$$aElderly population
000178372 650_7 $$2Other$$aHealthy ageing
000178372 650_7 $$2Other$$aPopulation-based cohort study
000178372 7001_ $$aEfremov, Ljupcho$$b1
000178372 7001_ $$aGroßkopf, Anne$$b2
000178372 7001_ $$aKartschmit, Nadja$$b3
000178372 7001_ $$aMedenwald, Daniel$$b4
000178372 7001_ $$aSchott, Artjom$$b5
000178372 7001_ $$aSchmidt-Pokrzywniak, Andrea$$b6
000178372 7001_ $$aLacruz, Maria E$$b7
000178372 7001_ $$aTiller, Daniel$$b8
000178372 7001_ $$aKraus, Frank Bernhard$$b9
000178372 7001_ $$0P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aGreiser, Karin H$$b10$$udkfz
000178372 7001_ $$aHaerting, Johannes$$b11
000178372 7001_ $$aWerdan, Karl$$b12
000178372 7001_ $$aSedding, Daniel$$b13
000178372 7001_ $$aSimm, Andreas$$b14
000178372 7001_ $$aNuding, Sebastian$$b15
000178372 7001_ $$00000-0003-4446-9938$$aKluttig, Alexander$$b16
000178372 7001_ $$aMikolajczyk, Rafael$$b17
000178372 773__ $$0PERI:(DE-600)2004992-4$$a10.1007/s10654-021-00824-7$$p103–116$$tEuropean journal of epidemiology$$v37$$x0393-2990$$y2022
000178372 909CO $$ooai:inrepo02.dkfz.de:178372$$pVDB
000178372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000178372 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000178372 9141_ $$y2022
000178372 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2021-01-28$$wger
000178372 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000178372 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000178372 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000178372 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2022-11-17$$wger
000178372 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-17
000178372 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-17
000178372 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-17
000178372 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-17
000178372 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-17
000178372 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-17
000178372 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-17
000178372 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J EPIDEMIOL : 2021$$d2022-11-17
000178372 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bEUR J EPIDEMIOL : 2021$$d2022-11-17
000178372 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000178372 980__ $$ajournal
000178372 980__ $$aVDB
000178372 980__ $$aI:(DE-He78)C020-20160331
000178372 980__ $$aUNRESTRICTED